Metabolix
Natural health product licensed in Canada
- Other names
- KONIG Metabolix, Konig Metabolix Ampk, Metabolix AMPK, Metabolix Ampk, Metagen AMPK, MetagenRx (TM), Metagene Pro, Metagenerex (TM)
- Licence holder
- Provita Nutrition and Health Inc.
- NPN or DIN-HM
- 80088745
- Status
- Active licence
- Licence date
- 16 October 2018
- Revision date
- 28 September 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Trigonella foenum-graecum Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 2,000 mg | 100 mg | Not calculated |
| Hydrastis canadensis Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,000 mg | 100 mg | Not calculated |
| (2S)-7-[[6-O-(6-Déoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-méthoxyphényl)-4H-1-benzopyrane-4-one Source : Bioflavonoïdes d'agrumes | 150 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Provides antioxidants. Used in Herbal Medicine to help reduce elevated blood lipid levels. Helps to promote healthy glucose metabolism.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you are pregnant or breastfeeding, do not use.
- Précautions et mises en garde
If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. If you are taking prescription medications, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you have a kidney disorder. Consult a health care practitioner prior to use if you have blood pressure problems. Consumption of Goldenseal with alcohol, other medications and/or natural health products with sedative properties is not recommended. If you have diabetes, consult a health care practitioner prior to use. If you experience symptoms of hypoglycaemia including feelings of anxiety, dizziness, tremor, sweating, nausea or headache, discontinue use and consult a health care practitioner.
Source
Official Health Canada record, licence 80088745
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging